Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Ann Rheum Dis. 2010 Dec 3;70(3):454–462. doi: 10.1136/ard.2010.130138

Table 2.

Genotype and allele frequencies for rs33996649 and rs2476601 PTPN22 polymorphisms in healthy controls and patients with SSc from eight countries

SNP Population GG GA AA G A p Value* OR (95% CI)
rs33996649 Spain SSc (n=599) 0.960 0.040 0 0.979 0.0211
Controls (n=1128) 0.932 0.068 0 0.966 0.0341 0.04 0.58 0.36 to 0.92
Belgium SSc (n=187) 0.952 0.048 0 0.976 0.0241
Controls (n=236) 0.949 0.051 0 0.975 0.0254 0.9 0.95 0.39 to 2.27
England SSc (n=477) 0.956 0.042 0.002 0.977 0.0231
Controls (n=382) 0.969 0.031 0 0.984 0.0157 0.28 1.48 0.73 to 3.01
Germany SSc (n=354) 0.966 0.034 0 0.983 0.0169
Controls (n=285) 0.958 0.042 0 0.979 0.0211 0.59 0.8 0.36 to 1.8
Italy SSc (n=419) 0.945 0.055 0 0.973 0.0274
Controls (n=371) 0.938 0.062 0 0.969 0.0310 0.68 0.88 0.49 to 1.59
Netherlands SSc (n=185) 0.959 0.041 0 0.979 0.0207
Controls (n=263) 0.951 0.049 0 0.975 0.0247 0.72 0.83 0.32 to 2.22
USA SSc (n=1050) 0.947 0.053 0 0.973 0.0267
Controls (n=693) 0.958 0.042 0 0.979 0.0209 0.28 1.28 0.81to 2.02
Sweden SSc (n=191) 0.974 0.026 0 0.987 0.0131
Controls (n=280) 0.946 0.054 0 0.973 0.0268 0.15 0.48 0.17 to1.34
Pooled† SSc(n=3422) 0.954 0.045 0 0.977 0.0230
Controls (n=3638) 0.947 0.053 0 0.973 0.0530
Fixed model 0.36 0.89 0.72 to 1.12

SNP Population CC CT TT C T p Value* OR (95% CI)

rs2476601 Spain SSc (n=636) 0.857 0.137 0.006 0.925 0.075
Controls (n=1128) 0.857 0.136 0.007 0.925 0.075 0.98 0.99 0.77 to 1.29
Belgium SSc (n=189) 0.788 0.212 0.000 0.894 0.106
Controls (n=256) 0.859 0.129 0.012 0.927 0.073 0.08 1.51 0.95 to 2.42
England SSc (n=463) 0.793 0.201 0.006 0.893 0.107
Controls (n=373) 0.853 0.147 0.000 0.926 0.074 0.04 1.5 1.07 to 2.12
Germany SSc (n=343) 0.802 0.175 0.023 0.889 0.111
Controls (n=288) 0.774 0.212 0.014 0.880 0.120 0.62 0.92 0.65 to 1.3
Italy SSc (n=383) 0.890 0.104 0.005 0.943 0.057
Controls (n=371) 0.935 0.059 0.005 0.965 0.035 0.08 1.68 1.02 to 2.76
Netherlands SSc (n=190) 0.805 0.189 0.005 0.900 0.100
Controls (n=277) 0.819 0.177 0.004 0.908 0.092 0.68 1.1 0.7 to 1.71
Sweden SSc (n=175) 0.789 0.200 0.011 0.889 0.111
Controls (n=279) 0.789 0.190 0.022 0.884 0.116 0.82 0.95 0.62 to 1.45
Dieudé et al19 SSc (n=1018) 0.820 0.172 0.008 0.906 0.094
Controls (n=1004) 0.828 0.163 0.009 0.909 0.091 0.73 1.04 0.84 to 1.28
Gourh et al20 SSc (n=666) 0.787 0.203 0.011 0.888 0.112
Controls (n=430) 0.844 0.147 0.009 0.917 0.083 0.06 1.39 1.03 to 1.87
Pooled§ SSc (n=4063) 0.819 0.173 0.009 0.905 0.095
Controls (n=4406) 0.843 0.148 0.008 0.917 0.083
Fixed model 0.03 1.15 1.03 to 1.28
*

p Value for the minor allele.

I2=17.6%, Breslow–Day p=0.281 Q=8.49 p=0.29; The statistical power for this pooled analysis was 97%.

The authors of those papers provided by personal communication the actualisation and specific data of their works.

§

I2=33.8%, Breslow–Day p=0.145 Q=12.08 p=0.15. The statistical power for this pooled analysis was 100%.

False discovery rate correction p value.

SNP, single nucleotide polymorphism; SSc, systemic sclerosis.